MGMT and cancer: Cancer cells that have enhanced DNA repair capacity, such as increased expression or activity of DNA repair enzymes like O6-methylguanine-DNA methyltransferase (MGMT), nucleotide excision repair (NER) proteins, or homologous recombination (HR) factors, can efficiently repair the DNA lesions induced by alkylating agents, promoting survival and resistance to therapy [5,6,7].